LDL Cholesterol, Hypertension, and Stroke Subtype among Hospitalized Patients in Palangka Raya
DOI:
https://doi.org/10.22487/yszqas39Keywords:
Cross sectional study, Hypertension, Ischemic stroke, LDL cholesterol, Medical recordsAbstract
Background: Low density lipoprotein cholesterol and hypertension are established vascular risk factors, but their associations with stroke subtype require careful evaluation in hospital based populations. Objectives: To examine associations of LDL cholesterol and hypertension with ischemic versus other stroke diagnoses among hospitalized stroke patients. Methods: This observational cross sectional study analyzed retrospective records from RSUD dr. Doris Sylvanus, Palangka Raya, from January to December 2024. Purposive sampling included 142 of 352 records, comprising 107 ischemic and 35 other stroke diagnoses. Unadjusted odds ratios (ORs), 95% confidence intervals (CIs), and two sided tests were calculated from aggregate counts. Results: High LDL was associated with ischemic stroke classification (OR 2.90; 95% CI 1.26–6.67; p=0.010). Reconstruction from the internally consistent joint exposure table yielded an OR of 2.74 for hypertension (95% CI 1.17–6.38; p=0.017). Compared with normal LDL without hypertension, high LDL with hypertension had OR 4.00 (95% CI 1.57–10.22; Fisher p=0.004). Hypertension counts require confirmation because source tables were inconsistent. Conclusions: High LDL was associated with greater odds of ischemic rather than other stroke diagnoses. These analyses do not establish incidence, causality, independent effects, or interaction.
Downloads
References
1. GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973–1003. doi:10.1016/S1474-4422(24)00369-7
2. Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132–144. doi:10.1177/17474930241308142
3. Badan Kebijakan Pembangunan Kesehatan, Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia 2023 dalam angka. Published 2024. Accessed October 1, 2026. https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/
4. Campbell BCV, De Silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. doi:10.1038/s41572-019-0118-8
5. Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–533. doi:10.1038/s41586-021-03392-8
6. Ference BA, Ginsberg HN, Graham I, et al. Low density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–2472. doi:10.1093/eurheartj/ehx144
7. Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–2149. doi:10.1177/0271678X18800589
8. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-2
9. O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case control study. Lancet. 2016;388(10046):761–775. doi:10.1016/S0140-6736(16)30506-2
10. Wang C, Du Z, Ye N, et al. Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China. BMC Cardiovasc Disord. 2022;22(1):47. doi:10.1186/s12872-022-02491-2
11. Bushnell C, Kernan WN, Sharrief AZ, et al. 2024 Guideline for the primary prevention of stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2024;55(12):e344–e424. doi:10.1161/STR.0000000000000475
12. Handayani F, Bintang AK, Kaelan C. Hubungan hipertensi, diabetes mellitus dan dislipidemia dengan luaran klinis pasien iskemik stroke dengan hipersomnia. Healthy Tadulako J. 2018;4(1):1–6. doi:10.22487/htj.v4i1.56
13. Minarti DL, Bintang AK, Akbar M, Aulina S, Bahar A, Idris I. Efek neuroprotektif brain derived neurotrophic factor (BDNF) dengan tingkat depresi pasca stroke iskemik: studi cross sectional. Healthy Tadulako J. 2024;10(3):379–386. doi:10.22487/htj.v10i3.1246
14. Husnawati, Andriani DM, Rizki FY, et al. Case report: 60 year old female with ischemic stroke, type 2 diabetes mellitus, and hypertension. Healthy Tadulako J. 2025;11(2):188–194. doi:10.22487/htj.v11i2.1564
15. Sumarni, Sari P. Surveilans petanda kardiometabolik pada sivitas akademika Universitas Tadulako. Healthy Tadulako J. 2018;4(1):15–21. doi:10.22487/htj.v4i1.58
16. Palesa H, Sridani NW. Faktor faktor yang berhubungan dengan penderita hipertensi di RSU Anutapura Palu Provinsi Sulawesi Tengah. Healthy Tadulako J. 2019;5(2):63–71. doi:10.22487/htj.v5i2.122
17. Halim YD, Widjaya IF. The relationship between age and cerebral small vessel disease on brain MRI at Royal Taruma Hospital. Healthy Tadulako J. 2026;12(3):386–394. doi:10.22487/n106a214
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi:10.1371/journal.pmed.0040296
19. Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885
20. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
21. Lang TA, Altman DG. Basic statistical reporting for articles published in biomedical journals: the Statistical Analyses and Methods in the Published Literature, or SAMPL guidelines. Int J Nurs Stud. 2015;52(1):5–9. doi:10.1016/j.ijnurstu.2014.09.006
22. Yoon CW, Bushnell CD. Stroke in women: a review focused on epidemiology, risk factors, and outcomes. J Stroke. 2023;25(1):2–15. doi:10.5853/jos.2022.03468
23. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. doi:10.1161/STR.0000000000000375
24. Amarenco P, Bogousslavsky J, Callahan A III, et al. High dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–559. doi:10.1056/NEJMoa061894
25. Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382(1):9–19. doi:10.1056/NEJMoa1910355
26. PROGRESS Collaborative Group. Randomised trial of a perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–1041. doi:10.1016/S0140-6736(01)06178-5
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Christina Natalia Anugrahni, Tisha Patricia, Dileli Dharma Astoeti, Lia Sasmithae, Agil Saputra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
